Carisma Therapeutics Inc. (CARM) — Cash Flow Quality Index
Carisma Therapeutics Inc. (CARM) has a Cash Flow Quality Index of 0.04x as of September 2025. Operating cash flow of $1.91 Million is below net income of $44.72 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore CARM total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Carisma Therapeutics Inc. Cash Flow Quality Index (2016–2016)
Historical Cash Flow Quality Index for Carisma Therapeutics Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Carisma Therapeutics Inc. tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Carisma Therapeutics Inc. (2016–2016)
Year-by-year earnings quality comparison for Carisma Therapeutics Inc.. For live market cap and the full company financial profile, see CARM stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2016 | 1.39x | $2.62 Million | $1.89 Million | — |